Meticulous Research®—a leading global market research company published a research report titled “Diagnostic Specialty Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB, Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria, Hepatitis, HIV, E. coli , Tuberculosis, Pneumonia, Cancer)- Forecast to 2029”. According to this latest publication from Meticulous Research®, the global diagnostic specialty antibodies market is expected to grow at a CAGR of 4.6% to reach $39.99 billion by 2029.
The high burden of infectious and chronic diseases worldwide, the availability of funding for research activities, the significant demand for pregnancy test kits due to rising incidences of pregnancies, and regulatory approval of test kits are the key factors driving the demand for diagnostic specialty antibodies. The initiatives taken by the public and private organizations to increase diagnostic testing and the increasing incidences of diseases in emerging countries are expected to offer significant opportunities for the growth of this market.
Download Sample Copy Here: https://www.meticulousresearch.....com/download-sample
Diagnostic Specialty Antibodies Market: Future Outlook
The global diagnostic specialty antibodies market is segmented based on Type (Primary Antibodies, Secondary Antibodies), Clonality (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies), Technique (Western Blot [WB], Lateral Flow Assay, Enzyme-Linked Immunosorbent Assay [ELISA], Immunohistochemistry [IHC], Immunoprecipitation [IP], Immunocytochemistry [ICC], Other Techniques), Conjugate (Conjugated, Unconjugated), Application (Infectious Diseases [Parasitic Infections: Dengue, Malaria, and Other Parasitic Infections], [Blood Borne Infections: Hepatitis, HIV, and Other Blood Borne Infections], [Gastrointestinal Infections: Salmonellosis, E. Coli Infections, and Other Gastrointestinal Infections], [Respiratory Infections: COVID-19, Tuberculosis, Pneumonia, Influenza, and Other Respiratory Infections], Oncology, Pregnancy Detection/Fertility Testing, and Other Applications), and Geography The study also evaluates industry competitors and analyzes their market share at the global and regional levels.
Based on clonality, the market is segmented into monoclonal, polyclonal, and recombinant. The recombinant antibody segment is expected to witness the fastest CAGR during the forecast period. Recombinant antibodies can be produced in a shorter duration than other clonal antibodies. These antibodies are more cost-effective and offer a better affinity to bind to the target antigen. Moreover, recombinant antibodies eliminate the problems associated with hybridomas, which further contributes to its demand in the market.
Have Any Query ? Speak to Our Analyst : https://www.meticulousresearch.....com/speak-to-analys